1.Characterization of monoclonal antibodies against human cytomegalovirus(HCMV) glycoprotein.
Eung Soo HWANG ; Ju Young SEOH ; Chung Gyu PARK ; Yoon Hoh KOOK ; Chang Yong CHA
Journal of the Korean Society for Microbiology 1992;27(6):545-553
No abstract available.
Antibodies, Monoclonal*
;
Glycoproteins*
;
Humans*
2.Glycoprotein g III of aujesky's disease virus espressed in insect cells by a baculovirus.
Jae Young SONG ; Jung Bok LEE ; Bang Hun HYUN ; Jong Hyeon PARK ; Byoung Han KIM ; Chang Hee KWEON ; Moo Hyung JUN ; Soo Hwan AN
Journal of the Korean Society of Virology 1992;22(2):119-128
No abstract available.
Baculoviridae*
;
Glycoproteins*
;
Insects*
3.Partly purification of urinastatin by using affinity chromatography
Journal of Medical Research 1998;8(4):34-39
A human urinary trypsin inhibitor (UTI) was purified by 80% amonium sulfat precipitation, affnity chromatography using trypsin cellulofine gel. Specificity inhibitory activity of solution after affinity chromatography was increase from 0.8 to 29.1 and its recovery was 20.8%. The reslt indicated that binding of trypsin to formyl- cellulofine and the affinity chromatography with trypsin cellulofine gel was successful. Capalary electrophoresis of urine, solutions before and after affinity chromatography also supported the above result.
Glycoproteins
;
Chromatography, Affinity
4.Composition of glycoproteins in goblet cells and submucosal glands.
Joo Heon YOON ; Jeung Gweon LEE ; In Yong PARK ; Mi Sook CHANG
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(4):732-736
No abstract available.
Glycoproteins*
;
Goblet Cells*
5.A quantitative study on the secretory cells contained various glycoproteins according to the histamine sensitivity in perennial allergic rhinitis.
Joo Heon YOON ; Jeung Gweon LEE ; In Yong PARK ; Yang Gi MIN
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(3):505-518
No abstract available.
Glycoproteins*
;
Histamine*
;
Rhinitis*
6.Prominin-1 and Its Role in Tumor Progression and Assessment of Clinical Prognosis in Systemic Malignancies.
Journal of Breast Cancer 2013;16(2):244-244
No abstract available.
Antigens, CD
;
Glycoproteins
;
Peptides
;
Prognosis
7.Successful Coronary Interventions with the Aid of Abciximab (ReoPro (R)) in High-Risk Patients: Report of Two Cases.
Woo Suck PARK ; Myung Ho JEONG ; Nam Ho KIM ; Young Keun AHN ; Youl BAE ; Gwang Chae GILL ; Joo Hyung PARK ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
The Korean Journal of Critical Care Medicine 1998;13(2):254-260
Abrupt closure of coronary artery during coronary intervention is one of major limitations especially in high-risk patients. Platelets are responsible for composing acute thrombotic occlusion at the site of therapeutic arterial injury. Abciximab (platelet glycoprotein IIb/IIIa receptor blocker) might be helpful in preventing the acute thrombotic occlusion. We experienced an excellent effects of the drug in two cases of high-risk patients, unsuccessful thrombolytics and PTCA with acute occlusion. With additional use of abciximab we overcame the complications and succeeded in getting normal coronary flow and resultant successful angioplasties.
Angioplasty
;
Coronary Vessels
;
Glycoproteins
;
Humans
8.The Relationship between Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and the Rubella Virus.
Seok Jin CHOI ; Dan A OH ; Woochang CHUN ; Sung Min KIM
Journal of Clinical Neurology 2018;14(4):598-600
No abstract available.
Glycoproteins*
;
Oligodendroglia*
;
Rubella virus*
;
Rubella*
9.The effects of RU 41.740, a glycoprotein extract from klebsiella pneumoniae, on peripheral blood mononuclear cells.
Moon Kyu KIM ; Dong Soo KIM ; Hyun Ok KIM
Journal of the Korean Pediatric Society 1992;35(8):1066-1072
No abstract available.
Glycoproteins*
;
Immunity, Cellular
;
Klebsiella pneumoniae*
;
Klebsiella*
10.Rapid N-glycosylation profiling of glycoprotein based on ultrafiltration-devices.
Cai TIE ; Ting HU ; Jin-lan ZHANG
Acta Pharmaceutica Sinica 2015;50(6):755-759
With development of bio-technique, more and more proteins were applied as clinical approaches. However, the protein homogeneity, especially the N-glycosylation limited the further research and application of these protein drugs. The analysis method for N-glycans is believed to be critical in protein drugs development. To enhance the N-glycans isolation efficiency and accelerate the pretreatment, a new strategy was built on ultrafiltration-devices. New methods increased the isolation efficiency of N-glycans containing N-acetylglucosa mine with 10%-20%. The degrading of N-glycans containing sialic acids was also minimized with this method. 20%-100% more N-glycans with sialic acids were isolated. The pretreatment was finished within 30 min. Coupled with HPLC-HRMS, an effective and reliable strategy designed for protein drugs N-glycans analysis were developed.
Glycoproteins
;
chemistry
;
Glycosylation
;
Polysaccharides
;
chemistry
;
Ultrafiltration
;
instrumentation
Result Analysis
Print
Save
E-mail